BackNektar Therapeutics Overview
Nektar Therapeutics

Nektar Therapeutics Return on Equity

Return on Equity (ROE) for NKTR.

Get informed when a big investor buys or sells

+ Follow

ROE

-27.44%

Return on Equity

-27.44%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading